BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:15 PM
 | 
Aug 26, 2009
 |  BC Extra  |  Company News

EMEA accepts IV vernakalant MAA

EMEA accepted for review an MAA from Merck & Co. Inc. (NYSE:MRK) for IV vernakalant to treat acute atrial fibrillation. Merck...

Read the full 86 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >